Skip to main content
Premium Trial:

Request an Annual Quote

Money Where the Eye Is

The eye is drawing the most venture capital funding, according to the Wall Street Journal.

The Journal's Brian Gormley sifted through data on what sorts of startups were getting VC money, and then went through them body part by body part to see which ones were getting the most funding.

Eye-related startups, Gormley reports, received $848.9 million last year and have received $442.7 million so far this year. "Investment has surged because of rising demand for better treatments and technological advances that are making improvements possible," Gormley says, noting that some 3 million people in the US over the age of 40 have impaired vision or are blind.

There's also rising interest in the ears, Gormley says, adding that hearing loss and related issues affect a third of people in the US between the ages of 65 and 74. Hearing-related startups garnered $76.2 million last year, and, in the first half of this year, they have raised $114.4 million.

Interest in cardiovascular and orthopedic startups remains high, Gormley notes, though investors are concerned about regulatory delays.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.